Author: Pooladanda, Venkatesh; Thatikonda, Sowjanya; Godugu, Chandraiah
Title: The current understanding and potential therapeutic options to combat COVID-19 Cord-id: 3zy5dgxz Document date: 2020_5_8
ID: 3zy5dgxz
Snippet: Abstract The ongoing wreaking global outbreak of the novel human beta coronavirus (CoV) pathogen was presumed to be from a seafood wholesale market in Wuhan, China, belongs to the Coronaviridae family in the Nidovirales order. The virus is highly contagious with potential human-human transmission which was named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread across six continents and emerged as a global pandemic in short span with alarming levels of spread and se
Document: Abstract The ongoing wreaking global outbreak of the novel human beta coronavirus (CoV) pathogen was presumed to be from a seafood wholesale market in Wuhan, China, belongs to the Coronaviridae family in the Nidovirales order. The virus is highly contagious with potential human-human transmission which was named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread across six continents and emerged as a global pandemic in short span with alarming levels of spread and severity. This virus associated symptoms and infectious respiratory illness is designated as coronavirus disease 19 (COVID-19). The SARS-CoV-2 possesses enveloped club-like spike protein projections with positive-sense large RNA genome and has a unique replication strategy. This virus was believed to have zoonotic origin with genetical identity to bat and pangolin CoV. In the current review, we introduce a general overview about the human CoVs and the associated diseases, the origin, structure, replication and key clinical events that occur in the COVID-19 pathogenicity. Furthermore, we focused on possible therapeutic options such as repurposing drugs including antimalarials, antivirals, antiparasitic drugs, and anti-HIV drugs, as well as monoclonal antibodies, vaccines as potential treatment options. Also we have summarized the latest research progress on the usage of stem cell therapy, human convalescent serum, interferon's, in the treatment of COVID-19.
Search related documents:
Co phrase search for related documents- ace inhibitor and long period: 1
- ace inhibitor and long short: 1
- ace inhibitor and long short term: 1
- acquire immunity and local site: 1
- activator signal transducer and adaptive immunity: 1, 2
- activator signal transducer and long short: 1
- active metabolite and local site: 1
- active monitoring and long period: 1, 2
- active monitoring and long short: 1
- acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and local site: 1
- acute ards respiratory distress syndrome and long period: 1, 2
- acute ards respiratory distress syndrome and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute cardiac injury and adequate level: 1
- acute cardiac injury and long period: 1
- acute cardiac injury and long short: 1, 2
- acute inflammation and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute inflammation and long period: 1
- acute inflammation and long short: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date